Does THIOTEPA Cause Venoocclusive liver disease? 306 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 306 reports of Venoocclusive liver disease have been filed in association with THIOTEPA (Thiotepa). This represents 4.5% of all adverse event reports for THIOTEPA.
306
Reports of Venoocclusive liver disease with THIOTEPA
4.5%
of all THIOTEPA reports
115
Deaths
59
Hospitalizations
How Dangerous Is Venoocclusive liver disease From THIOTEPA?
Of the 306 reports, 115 (37.6%) resulted in death, 59 (19.3%) required hospitalization, and 27 (8.8%) were considered life-threatening.
Is Venoocclusive liver disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for THIOTEPA. However, 306 reports have been filed with the FAERS database.
What Other Side Effects Does THIOTEPA Cause?
Off label use (762)
Febrile neutropenia (645)
Mucosal inflammation (616)
Cytomegalovirus infection (446)
Product use in unapproved indication (425)
Pyrexia (359)
Drug ineffective (358)
Acute graft versus host disease in skin (355)
Acute graft versus host disease (331)
Cytomegalovirus infection reactivation (325)
What Other Drugs Cause Venoocclusive liver disease?
CYCLOPHOSPHAMIDE (911)
BUSULFAN (765)
FLUDARABINE (649)
VINCRISTINE (616)
METHOTREXATE (590)
CYTARABINE (573)
ETOPOSIDE (523)
OXALIPLATIN (521)
MELPHALAN (464)
DEXAMETHASONE (371)
Which THIOTEPA Alternatives Have Lower Venoocclusive liver disease Risk?
THIOTEPA vs THIOTHIXENE
THIOTEPA vs THROMBIN
THIOTEPA vs THROMBIN HUMAN
THIOTEPA vs THYMOCYTE IMMUNE GLOBULIN NOS
THIOTEPA vs THYMOGLOBULINE